Search Results for Prostate -- Cancer.

13.

Investigation of stilbene-fused chalcone and flavanone derivatives for their cytotoxic and anti-cancer properties

Odacı, Burcu.

Access to Electronic Versiyon.

Format:

El Yazması

Alıntı:

flavanones were tested for their cytotoxic activities in prostate cancer cell line (PC-3) and breast cancer

14.

Synthesis and characterization of monodispere silica based functional nanoparticles for multi-purpose applications

Altın, Burcu.

Access to Electronic Version.

Format:

El Yazması

Alıntı:

particles against MCF-7 (human breast cancer cell lines) and PC-3 (human prostate cancer cell lines) cancer

15.

Docking studies on selected sapogenins targeting androgen and estrogen receptors

Çömlekçi, Yiğit Ege, author.

Access to Electronic Versiyon.

Format:

El Yazması

Alıntı:

such as prostate and estrogen alpha-mediated breast cancer and exert their effects via the androgen and

16.

Investigation of anticancer properties of novel mdm2 inhibitors

Özdemir, Sefayi Merve, author.

Access to Electronic Versiyon.

Format:

El Yazması

Alıntı:

cancer therapeutics. One of the most important strategy for cancer treatment is the reactivation of p53

17.

Synthesis of novel 6,7-dihydro-5h-oxepin-2-one derivatives

Kayar, Burcu.

Access to Electronic Versiyon.

Format:

El Yazması

Alıntı:

linker modified analog of goniothalamin was shown to be cytotoxic against PC-3 (prostate cancer) and MCF

18.

Developing spreadable peanut butters incorporated with the encapsulated potential psychobiotic Lactococcus lactis C19.1 strain

Akkuş, Zeynep Aysun, author.

Access to Electronic Versiyon.

Format:

El Yazması

Alıntı:

to reduce the risk of prostate, liver, colon and lung cancer and stress-related diseases. In this

19.

PEG-peptide drug carrier systems with enzymatic degradation units

Yüksel, Nesligül, author.

Access to Electronic Versiyon.

Format:

El Yazması

Alıntı:

lung cancer (A549) and prostate cancer (PC3) cell lines. At the end of 24 hours the absolute IC50

	{displayName}	{count}
{error}